Today’s Stock On Watch: Institutional Investor Sentiment About Colgate Palmolive Co (NYSE:CL) Increased

November 24, 2016 - By Dolores Ford   ·   0 Comments

Today's Stock On Watch: Institutional Investor Sentiment About Colgate Palmolive Co (NYSE:CL)  Increased

Sentiment for Colgate Palmolive Co (NYSE:CL)

Colgate Palmolive Co (NYSE:CL) institutional sentiment increased to 0.89 in Q2 2016. Its up 0.02, from 0.87 in 2016Q1. The ratio is more positive, as 424 investment managers opened new or increased equity positions, while 487 sold and reduced equity positions in Colgate Palmolive Co. The investment managers in our partner’s database now hold: 618.55 million shares, down from 657.64 million shares in 2016Q1. Also, the number of investment managers holding Colgate Palmolive Co in their top 10 equity positions increased from 37 to 38 for an increase of 1. Sold All: 47 Reduced: 440 Increased: 371 New Position: 53.

Colgate-Palmolive Company is a consumer products company, whose products are marketed in over 200 countries and territories throughout the world. The company has a market cap of $58.75 billion. The Company’s divisions include Oral, Personal and Home Care, and Pet Nutrition. It has a 43.19 P/E ratio. The Oral, Personal and Home Care product segment is operated through over five geographic divisions, which include North America, Latin America, Europe/South Pacific, Asia and Africa/Eurasia.

The stock decreased 0.51% or $0.34 on November 23, hitting $65.99. About 2.23 million shares traded hands. Colgate-Palmolive Company (NYSE:CL) has declined 4.45% since April 22, 2016 and is downtrending. It has underperformed by 9.85% the S&P500.

Analysts await Colgate-Palmolive Company (NYSE:CL) to report earnings on February, 3. They expect $0.76 earnings per share, up 4.11% or $0.03 from last year’s $0.73 per share. CL’s profit will be $676.62M for 21.71 P/E if the $0.76 EPS becomes a reality. After $0.73 actual earnings per share reported by Colgate-Palmolive Company for the previous quarter, Wall Street now forecasts 4.11% EPS growth.

According to Zacks Investment Research, “Colgate-Palmolive is a leading global consumer products company, tightly focused on Oral Care, Personal Care, Household Surface Care, Fabric Care and Pet Nutrition. Colgate sells its products in countries and territories around the world under such internationally recognized brand names as Colgate, Palmolive, Mennen, Softsoap, Irish Spring, Protex, Sorriso, Kolynos, Ajax, Axion, Soupline, Suavitel and Fab, as well as Hill’s Science Diet and Hill’s Prescription Diet pet foods. (Company Press Release)”

Ycg Llc holds 10.48% of its portfolio in Colgate-Palmolive Company for 447,886 shares. Caledonia Investments Plc owns 240,000 shares or 6.57% of their US portfolio. Moreover, Palisades Hudson Asset Management L.P. has 6.22% invested in the company for 104,314 shares. The Missouri-based Bush Odonnell Investment Advisors Inc has invested 6.21% in the stock. Troy Asset Management Ltd, a United Kingdom-based fund reported 1.41 million shares.#img1#

Insider Transactions: Since January 1, 0001, the stock had 0 buys, and 12 sales for $11.28 million net activity.

Colgate-Palmolive Company (NYSE:CL) Ratings Coverage

Ratings analysis reveals 18% of Colgate-Palmolive’s analysts are positive. Out of 17 Wall Street analysts rating Colgate-Palmolive, 3 give it “Buy”, 0 “Sell” rating, while 14 recommend “Hold”. The lowest target is $65 while the high is $88. The stock’s average target of $72.63 is 10.06% above today’s ($65.99) share price. CL was included in 30 notes of analysts from July 21, 2015. The firm has “Hold” rating by Zacks given on Wednesday, August 5. As per Monday, March 21, the company rating was maintained by Barclays Capital. The stock has “Hold” rating given by S&P Research on Monday, November 2. The rating was maintained by UBS with “Neutral” on Friday, April 29. The stock of Colgate-Palmolive Company (NYSE:CL) earned “Market Perform” rating by Wells Fargo on Tuesday, November 15. The firm has “Outperform” rating by BNP Paribas given on Monday, January 18. The stock has “Buy” rating given by Bank of America on Monday, September 12. The rating was initiated by KeyBanc Capital Markets on Friday, September 9 with “Sector Weight”. The stock of Colgate-Palmolive Company (NYSE:CL) earned “Neutral” rating by Sterne Agee CRT on Friday, February 26. On Friday, October 28 the stock rating was maintained by UBS with “Neutral”.

CL Company Profile

Colgate-Palmolive Company (Colgate), incorporated on July 25, 1923, is a consumer products company, whose products are marketed in over 200 countries and territories throughout the world. The Firm operates in two product divisions: Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care product segment is operated through over five geographic divisions, which include North America, Latin America, Europe/South Pacific, Asia and Africa/Eurasia. The Company’s oral care products include Colgate Total; Colgate Sensitive Pro-Relief; Colgate Max Fresh; Colgate Maximum Cavity Protection with Sugar Acid Neutralizer; Colgate Optic White and Colgate Luminous White toothpastes, and Colgate Optic White, Colgate Total and Colgate Plax mouthwashes. Colgate’s Oral Care business also includes pharmaceutical products for dentists and other oral health professionals. The Firm sells its personal care products under the Palmolive, Protex and Softsoap brands. The Company, through its Hill’s Pet Nutrition segment (Hill’s), makes pet nutrition products for dogs and cats with products marketed in over 80 countries across the world.

More news for Colgate-Palmolive Company (NYSE:CL) were recently published by: Seekingalpha.com, which released: “Due Diligence? Brush Up On Colgate-Palmolive Before Investing” on November 18, 2016. Equitiesfocus.com‘s article titled: “Colgate-Palmolive Company (NYSE:CL) Fixes Dividend Payout At $0.39” and published on November 24, 2016 is yet another important article.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By Dolores Ford


Readers Comments (0)





Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


Recent Market News

>